This Article Full Text Full Text (PDF) All Versions of this Article: 107/9/1308    most recent 01.CIR.0000054623.35669.3Fv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nykänen, A. I. Articles by Lemström, K. B. Search for Related Content PubMed PubMed Citation Articles by Nykänen, A. I. Articles by Lemström, K. B. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Coronary Artery Disease Heart Transplantation Related Collections Gene therapy Mechanism of atherosclerosis/growth factors Related Article

(Circulation. 2003;107:1308.)
© 2003 American Heart Association, Inc.

Basic Science Reports

Angiopoietin-1 Protects Against the Development of Cardiac Allograft Arteriosclerosis

Antti I. Nykänen, MD; Rainer Krebs, MSc; Anne Saaristo, MD; Päivi Turunen, MSc; Kari Alitalo, MD, PhD; Seppo Ylä-Herttuala, MD, PhD; Petri K. Koskinen, MD, PhD; Karl B. Lemström, MD, PhD

From the Cardiopulmonary Research Group, Transplantation Laboratory (A.I.N., R.K., P.K.K., K.B.L.), University of Helsinki and Helsinki University Central Hospital; Department of Medicine, Division of Nephrology (P.K.K.), and Department of Cardiothoracic Surgery (K.B.L.), Helsinki University Central Hospital; Molecular Cancer Biology Laboratory (K.A., A.S.), Biomedicum Helsinki, University of Helsinki, Helsinki, and A.I. Virtanen Institute for Molecular Sciences (S.Y.-H., P.T.), University of Kuopio, Kuopio, Finland.

Correspondence to Karl Lemström, MD, Cardiopulmonary Research Group, Transplantation Laboratory, University of Helsinki and Helsinki University Central Hospital, P.O. Box 21 (Haartmaninkatu 3), FIN-00014 University of Helsinki, Finland. E-mail karl.lemstrom{at}helsinki.fi

Background— Angiopoietin (Ang)–1 is an angiogenic growth factor that counteracts the permeability and proinflammatory effects of vascular endothelial growth factor and other proinflammatory cytokines. Recently, we demonstrated that vascular endothelial growth factor enhances cardiac allograft arteriosclerosis. Here, we studied the roles of Ang1, its natural antagonist Ang2, and their receptor Tie2 in rat cardiac allograft arteriosclerosis.

Methods and Results— Heterotopic cardiac allografts and syngrafts were transplanted from Dark Agouti (DA) to Wistar-Furth rats and from DA to DA rats, respectively. Immunohistochemistry disclosed that only a few mesenchymal cells expressed Ang1 in normal hearts and syngrafts, whereas no immunoreactivity was found in cardiac allografts undergoing chronic rejection. Ang2 and Tie2 immunoreactivity was induced mainly in capillaries and postcapillary venules in chronic allografts when compared with syngeneic controls, but no immunoreactivity was found in arterial endothelium. Intracoronary perfusion of cardiac allografts with a clinical-grade adenoviral vector encoding human Ang1 (Ad.Ang1) protected against the development of allograft arteriosclerosis. Ad.Ang1 perfusion reduced Ang2 expression in microcirculation, the numbers of graft-infiltrating leukocytes, and the level of immunoactivation and interstitial fibrosis, as well as both the incidence and intensity of intimal lesions. Ad.Ang1 perfusion also increased CD34⁺ stem cell counts in peripheral blood.

Conclusions— Our findings suggest that the antiinflammatory properties of Ang1 may offer an entirely new therapeutic approach to prevent cardiac allograft arteriosclerosis.

Key Words: angiogenesis • endothelium • inflammation • arteriosclerosis • transplantation

Related Article:

Allograft Arteriosclerosis and Immune-Driven Angiogenesis

Peter Libby and David Xiao-Ming Zhao
Circulation 2003 107: 1237-1239. [Extract] [Full Text]

This article has been cited by other articles:

				Y. Feng, F. Jacobs, E. Van Craeyveld, C. Brunaud, J. Snoeys, M. Tjwa, S. Van Linthout, and B. De Geest Human ApoA-I Transfer Attenuates Transplant Arteriosclerosis via Enhanced Incorporation of Bone marrow-derived Endothelial Progenitor Cells Arterioscler. Thromb. Vasc. Biol., February 1, 2008; 28(2): 278 - 283. [Abstract] [Full Text] [PDF]

				D. Pfaff, U. Fiedler, and H. G. Augustin Emerging roles of the Angiopoietin-Tie and the ephrin-Eph systems as regulators of cell trafficking J. Leukoc. Biol., October 1, 2006; 80(4): 719 - 726. [Abstract] [Full Text] [PDF]

				A. I. Nykanen, K. Pajusola, R. Krebs, M. A.I. Keranen, O. Raisky, P. K. Koskinen, K. Alitalo, and K. B. Lemstrom Common Protective and Diverse Smooth Muscle Cell Effects of AAV-Mediated Angiopoietin-1 and -2 Expression in Rat Cardiac Allograft Vasculopathy Circ. Res., June 9, 2006; 98(11): 1373 - 1380. [Abstract] [Full Text] [PDF]

				N. P.J. Brindle, P. Saharinen, and K. Alitalo Signaling and Functions of Angiopoietin-1 in Vascular Protection Circ. Res., April 28, 2006; 98(8): 1014 - 1023. [Abstract] [Full Text] [PDF]

				M. E.J. Reinders, T. J. Rabelink, and D. M. Briscoe Angiogenesis and Endothelial Cell Repair in Renal Disease and Allograft Rejection J. Am. Soc. Nephrol., April 1, 2006; 17(4): 932 - 942. [Abstract] [Full Text] [PDF]

				M. Scharpfenecker, U. Fiedler, Y. Reiss, and H. G. Augustin The Tie-2 ligand Angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism J. Cell Sci., February 15, 2005; 118(4): 771 - 780. [Abstract] [Full Text] [PDF]

				H. S. Lim, A. D. Blann, A. Y. Chong, B. Freestone, and G. Y.H. Lip Plasma Vascular Endothelial Growth Factor, Angiopoietin-1, and Angiopoietin-2 in Diabetes: Implications for cardiovascular risk and effects of multifactorial intervention Diabetes Care, December 1, 2004; 27(12): 2918 - 2924. [Abstract] [Full Text] [PDF]

				U. Fiedler, M. Scharpfenecker, S. Koidl, A. Hegen, V. Grunow, J. M. Schmidt, W. Kriz, G. Thurston, and H. G. Augustin The Tie-2 ligand Angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies Blood, June 1, 2004; 103(11): 4150 - 4156. [Abstract] [Full Text] [PDF]

				K. G. Peters, C. D. Kontos, P. C. Lin, A. L. Wong, P. Rao, L. Huang, M. W. Dewhirst, and S. Sankar Functional Significance of Tie2 Signaling in the Adult Vasculature Recent Prog. Horm. Res., January 1, 2004; 59(1): 51 - 71. [Abstract] [Full Text]

				M. Ii and D. W. Losordo Transplant Graft Vasculopathy: A Dark Side of Bone Marrow Stem Cells? Circulation, December 23, 2003; 108(25): 3056 - 3058. [Full Text] [PDF]

				Y. Hu, F. Davison, Z. Zhang, and Q. Xu Endothelial Replacement and Angiogenesis in Arteriosclerotic Lesions of Allografts Are Contributed by Circulating Progenitor Cells Circulation, December 23, 2003; 108(25): 3122 - 3127. [Abstract] [Full Text] [PDF]

				A. Tadros, D. P. Hughes, B. J. Dunmore, and N. P. J. Brindle ABIN-2 protects endothelial cells from death and has a role in the antiapoptotic effect of angiopoietin-1 Blood, December 15, 2003; 102(13): 4407 - 4409. [Abstract] [Full Text] [PDF]

				E. IIVANAINEN, L. NELIMARKKA, V. ELENIUS, S.-M. HEIKKINEN, T. T. JUNTTILA, L. SIHOMBING, M. SUNDVALL, J. A. MAATTA, V. J. O. LAINE, S. YLA-HERTTUALA, et al. Angiopoietin-regulated recruitment of vascular smooth muscle cells by endothelial-derived heparin binding EGF-like growth factor FASEB J, September 1, 2003; 17(12): 1609 - 1621. [Abstract] [Full Text] [PDF]

				P. Libby and D. X.-M. Zhao Allograft Arteriosclerosis and Immune-Driven Angiogenesis Circulation, March 11, 2003; 107(9): 1237 - 1239. [Full Text] [PDF]